Top Markets
Coin of the day
BioLineRx Ltd. BioLineRx Ltd.

BioLineRx Ltd.

BLRX
Classement en actions #40526
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and... BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Prix de l'action
$0.0048574
Capitalisation boursière
$126.82K
Changement (1 jour)
0.00%
Changement (1 an)
-21.82%
Pays
IL
Échange BioLineRx Ltd. (BLRX)

Catégorie

Le prix BLRX avec la capitalisation boursière de B
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$0.0048574
Capitalisation boursière de BioLineRx Ltd.(BLRX)
Capitalisation boursière: $126.82K
En August 2026, BioLineRx Ltd. a une capitalisation boursière de $126.82K. Cela fait de BioLineRx Ltd. la 40526th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de BioLineRx Ltd. du 2007 au 2026
BLRX par rapport au top 5 des plus populaires stocks
Prix pour BLRX L’actif B La capitalisation boursière de B Résultats
BioLineRx Ltd. BioLineRx Ltd.
$209,349 $126.82K
$5.466T +4,309,898,327.99%
BioLineRx Ltd. BioLineRx Ltd.
$170,623 $126.82K
$4.455T +3,512,637,232.91%
BioLineRx Ltd. BioLineRx Ltd.
$159,777 $126.82K
$4.171T +3,289,349,919.50%
BioLineRx Ltd. BioLineRx Ltd.
$141,184 $126.82K
$3.686T +2,906,571,152.00%
BioLineRx Ltd. BioLineRx Ltd.
$109,686 $126.82K
$2.864T +2,258,126,551.15%